546 related articles for article (PubMed ID: 16009407)
1. Recurrence and prognostic factors in borderline ovarian tumors.
Ayhan A; Guvendag Guven ES; Guven S; Kucukali T
Gynecol Oncol; 2005 Sep; 98(3):439-45. PubMed ID: 16009407
[TBL] [Abstract][Full Text] [Related]
2. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
3. Borderline ovarian tumors in reproductive-age women. Fertility-sparing surgery and outcome.
Chan JK; Lin YG; Loizzi V; Ghobriel M; DiSaia PJ; Berman ML
J Reprod Med; 2003 Oct; 48(10):756-60. PubMed ID: 14619640
[TBL] [Abstract][Full Text] [Related]
4. Restaging surgery for women with borderline ovarian tumors: results of a French multicenter study.
Fauvet R; Boccara J; Dufournet C; David-Montefiore E; Poncelet C; Daraï E
Cancer; 2004 Mar; 100(6):1145-51. PubMed ID: 15022280
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study.
Suh-Burgmann E
Gynecol Oncol; 2006 Dec; 103(3):841-7. PubMed ID: 16793124
[TBL] [Abstract][Full Text] [Related]
6. Surgical management of borderline ovarian tumors: The role of fertility-sparing surgery.
Park JY; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2009 Apr; 113(1):75-82. PubMed ID: 19171373
[TBL] [Abstract][Full Text] [Related]
7. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long-term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma.
Kennedy AW; Hart WR
Cancer; 1996 Jul; 78(2):278-86. PubMed ID: 8674004
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathologic analysis of 130 cases of mucinous borderline ovarian tumors].
Cao DY; Shen K; Tao T; Yang JX; Xiang Y; Huang HF; Wu M; Pan LY; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):15-8. PubMed ID: 21429428
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up after ovarian borderline tumor: relapse and survival in a large patient cohort.
Lenhard MS; Mitterer S; Kümper C; Stieber P; Mayr D; Ditsch N; Friese K; Burges A
Eur J Obstet Gynecol Reprod Biol; 2009 Aug; 145(2):189-94. PubMed ID: 19477060
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors predicting recurrence in borderline ovarian tumors.
Wu TI; Lee CL; Wu MY; Hsueh S; Huang KG; Yeh CJ; Lai CH
Gynecol Oncol; 2009 Aug; 114(2):237-41. PubMed ID: 19481786
[TBL] [Abstract][Full Text] [Related]
11. The role of restaging borderline ovarian tumors: single institution experience and review of the literature.
Zapardiel I; Rosenberg P; Peiretti M; Zanagnolo V; Sanguineti F; Aletti G; Landoni F; Bocciolone L; Colombo N; Maggioni A
Gynecol Oncol; 2010 Nov; 119(2):274-7. PubMed ID: 20797775
[TBL] [Abstract][Full Text] [Related]
12. [Borderline ovarian tumors. Retrospective analysis of 20 cases].
Iervolino P; Palmieri M; Rotondi M; D'Alessandro P; Iuliano R
Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):97-9. PubMed ID: 11526732
[TBL] [Abstract][Full Text] [Related]
13. Behaviour of ovarian tumors of low malignant potential treated with conservative surgery.
De Iaco P; Ferrero A; Rosati F; Melpignano M; Biglia N; Rolla M; De Aloysio D; Sismondi P
Eur J Surg Oncol; 2009 Jun; 35(6):643-8. PubMed ID: 19013745
[TBL] [Abstract][Full Text] [Related]
14. Ten years experience in the management of borderline ovarian tumors at Tom Baker Cancer Centre.
Anfinan N; Sait K; Ghatage P; Nation J; Chu P
Arch Gynecol Obstet; 2011 Sep; 284(3):731-5. PubMed ID: 20963432
[TBL] [Abstract][Full Text] [Related]
15. Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumors of the ovary.
Abu-Rustum NR; Restivo A; Ivy J; Soslow R; Sabbatini P; Sonoda Y; Barakat RR; Chi DS
Gynecol Oncol; 2006 Oct; 103(1):31-4. PubMed ID: 16537089
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: oncologic safety and reproductive outcomes.
Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2008 Sep; 110(3):345-53. PubMed ID: 18586310
[TBL] [Abstract][Full Text] [Related]
17. Surgical staging of ovarian low malignant potential tumors.
Rao GG; Skinner E; Gehrig PA; Duska LR; Coleman RL; Schorge JO
Obstet Gynecol; 2004 Aug; 104(2):261-6. PubMed ID: 15291997
[TBL] [Abstract][Full Text] [Related]
18. Conservative surgery for borderline ovarian tumors: a review.
Tinelli R; Tinelli A; Tinelli FG; Cicinelli E; Malvasi A
Gynecol Oncol; 2006 Jan; 100(1):185-91. PubMed ID: 16216320
[TBL] [Abstract][Full Text] [Related]
19. Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome.
Gotlieb WH; Flikker S; Davidson B; Korach Y; Kopolovic J; Ben-Baruch G
Cancer; 1998 Jan; 82(1):141-6. PubMed ID: 9428490
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]